Arjun Desai
Director/Board Member bij TRISALUS LIFE SCIENCES, INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
Dr. Arjun M.
Desai, MD, is an Independent Director at Clene, Inc. and an Independent Director at TriSalus Life Sciences, Inc. He is on the Board of Directors at Clene, Inc. and TriSalus Life Sciences, Inc. Dr. Desai was previously employed as a Chief Medical Officer by Avinger, Inc. He received his undergraduate degree from the University of Oklahoma and a doctorate degree from The University of Miami Leonard M.
Miller School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 03-04-2024 | 203 127 ( 0.77% ) | 2 M $ | 31-03-2024 | |
CLENE INC
0.01% | 11-03-2024 | 16 298 ( 0.01% ) | 6 927 $ | 31-03-2024 |
Actieve functies van Arjun Desai
| Bedrijven | Functie | Begin |
|---|---|---|
| TRISALUS LIFE SCIENCES, INC. | Director/Board Member | 10-08-2023 |
| CLENE INC. | Director/Board Member | 18-09-2023 |
Eerdere bekende functies van Arjun Desai
| Bedrijven | Functie | Einde |
|---|---|---|
| AVINGER, INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Arjun Desai
| University of Oklahoma | Undergraduate Degree |
| The University of Miami Leonard M. Miller School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| AVINGER, INC. | Health Technology |
| CLENE INC. | Health Technology |
| TRISALUS LIFE SCIENCES, INC. | Health Technology |
